Worth reading
67In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
114
¥ millions (year-on-year change in operating income)Wording
Conditional
How definitive the wording is.Contents of this document
Earnings presentation materialsSecond quarter of the fiscal year ending March 20279 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥1,302 million+0.8%
Operating profit¥79 million
Ordinary income¥59 million
Net income¥19 million interim net income attributable to owners of the parent
Gross Profit Margin56.8% (calculated from a cost of sales ratio of 43.2%)
Operating profit margin6.1%
Selling, general and administrative expenses¥660 million
Results for the three months of the current quarter
Net Sales
¥663 million
Operating profit
¥48 million
Wellness Business Revenue
¥500 million
Wellness Business Operating Profit
¥43 million
Financial Business Revenue
¥163 million
Financial Business Operating Profit
¥4 million
Full-year earnings forecast
Net Sales
¥2,502 million
Operating profit
¥85 million
Ordinary income
¥51 million
Profit attributable to owners of the parent
¥2 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales52.0%
Operating profit93.0%
Ordinary income116.5%
Profit attributable to owners of the parent779.3%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
The first half remained strong. The operating profit and ordinary profit forecasts were revised upward from the initial forecasts for the fiscal year, and the Company is expected to finish the year in the black.Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Change in operating income
Revenue growth effect¥25 million
Impact of changes in gross margin¥-13 million
Impact of SG&A expenses¥139 million
Change in operating profit by segment
Wellness¥38 million
Financial Business¥75 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Temporary weakness in 3Q revenue, the transfer of a subsidiary's business, and higher preparation costs for IFMC.-related products are expected, but the numerical assumptions are Not disclosedNew initiatives
- A capital and business alliance with ストリートスマート and financing through a third-party allotment
- A next-generation container project using LIMEX with TBM
- Consideration of entry into the general medical device field using IFMC.
- Joint establishment of the NO Health Innovation Council
- A basic agreement with GREEN HOLDING SPORT for sales in Vietnam
- Transfer of ヒゴワン's web marketing business
Key KPIsA metric the company considers important as a management benchmark.
- Number of osteopathic clinics with transaction records5,747 clinics
- Number of clinics using IFMC.2,122 clinics
- New ANP¥446 million
- Number of new contracts267 cases
Segment results
Wellness
Net Sales
¥990 million+4.2%
Operating profit
¥71 million+118.8%
Financial Business
Net Sales
¥311 million-8.4%
Operating profit
¥7 million
Medium-term management plan targets
Period CoveredFiscal years ending March 2027 to March 2029
Net Sales
Fiscal year ending March 2027¥2,608 million
Fiscal year ending March 2028¥2,760 million
Fiscal year ending March 2029¥3,160 million
Operating profit
Fiscal year ending March 2027¥71 million
Fiscal year ending March 2028¥130 million
Fiscal year ending March 2029¥290 million
Market Size / Share
Market of group clinics with 10 or more clinics that transact with the company¥19 billion, approximately 2,000 clinics
Market of group clinics with 10 or more clinics that do not transact with the company¥82 billion, approximately 7,000 clinics
Judo therapy clinic market¥479 billion, approximately 51,000 clinics
Number of employees
Wellness Business Consultant
25 people
Financial Business insurance sales agents
24 people
| Item | Details |
|---|---|
| Document type | Earnings presentation materials |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥1,302 million (YoY +0.8%) |
| Operating profit | ¥79 million |
| Ordinary income | ¥59 million |
| Net income | ¥19 million (interim net income attributable to owners of the parent) |
| Gross Profit Margin | 56.8% (calculated from a cost of sales ratio of 43.2%) |
| Operating profit margin | 6.1% |
| Selling, general and administrative expenses | ¥660 million |
| Results for the three months of the current quarter | Net Sales ¥663 million / Operating profit ¥48 million / Wellness Business Revenue ¥500 million / Wellness Business Operating Profit ¥43 million / Financial Business Revenue ¥163 million / Financial Business Operating Profit ¥4 million |
| Full-year earnings forecast | Net Sales ¥2,502 million / Operating profit ¥85 million / Ordinary income ¥51 million / Profit attributable to owners of the parent ¥2 million |
| Progress against full-year forecast | Net Sales 52.0% / Operating profit 93.0% / Ordinary income 116.5% / Profit attributable to owners of the parent 779.3% |
| Self-assessment against the plan | The first half remained strong. The operating profit and ordinary profit forecasts were revised upward from the initial forecasts for the fiscal year, and the Company is expected to finish the year in the black. |
| Segment results | Wellness Net Sales ¥990 million (YoY +4.2%) / Operating profit ¥71 million (YoY +118.8%) / Financial Business Net Sales ¥311 million (YoY -8.4%) / Operating profit ¥7 million |
| Breakdown of Factors Affecting the Change | Change in operating income Revenue growth effect ¥25 million / Impact of changes in gross margin ¥-13 million / Impact of SG&A expenses ¥139 million / Change in operating profit by segment Wellness ¥38 million / Financial Business ¥75 million |
| Key KPIs | Indicator name Number of osteopathic clinics with transaction records / Value 5,747 clinics / Year on year against the same period last year Not disclosed, Indicator name Number of clinics using IFMC. / Value 2,122 clinics / Year on year against the same period last year Not disclosed, Indicator name New ANP / Value ¥446 million / Year on year against the same period last year Not disclosed, Indicator name Number of new contracts / Value 267 cases / Year on year against the same period last year Not disclosed |
| Number of employees | Wellness Business Consultant Value 25 people / Financial Business insurance sales agents Value 24 people |
| Assumptions Underlying the Business Outlook | Temporary weakness in 3Q revenue, the transfer of a subsidiary's business, and higher preparation costs for IFMC.-related products are expected, but the numerical assumptions are Not disclosed |
| Medium-term management plan targets | Period Covered Fiscal years ending March 2027 to March 2029 / Net Sales Fiscal year ending March 2027 ¥2,608 million / Fiscal year ending March 2028 ¥2,760 million / Fiscal year ending March 2029 ¥3,160 million / Operating profit Fiscal year ending March 2027 ¥71 million / Fiscal year ending March 2028 ¥130 million / Fiscal year ending March 2029 ¥290 million |
| Market Size / Share | Market of group clinics with 10 or more clinics that transact with the company ¥19 billion, approximately 2,000 clinics / Market of group clinics with 10 or more clinics that do not transact with the company ¥82 billion, approximately 7,000 clinics / Judo therapy clinic market ¥479 billion, approximately 51,000 clinics |
| New initiatives | A capital and business alliance with ストリートスマート and financing through a third-party allotment, A next-generation container project using LIMEX with TBM, Consideration of entry into the general medical device field using IFMC., Joint establishment of the NO Health Innovation Council, A basic agreement with GREEN HOLDING SPORT for sales in Vietnam, Transfer of ヒゴワン's web marketing business |
Items this document does not state (10)
Unit price and quantity metricsNumber of stores and locationsRisk amount incorporated into the outlookFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Wellness Business, the reasons cited for the increase in profit were higher revenue and lower selling, general and administrative expenses. In the Financial Business, the reasons were effective revenue growth in the insurance business and lower selling, general and administrative expenses following the business reorganisation. The reasons given for revising the full-year forecast were the expected weakness in 3Q revenue, the transfer of a consolidated subsidiary's business, higher preparation costs for IFMC.-related products, the subsidiary's tax expenses, and an extraordinary loss in 1Q.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.